Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization - PubMed (original) (raw)
. 2003 Aug;44(8):3586-92.
doi: 10.1167/iovs.03-0038.
Affiliations
- PMID: 12882811
- DOI: 10.1167/iovs.03-0038
Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization
Diego G Espinosa-Heidmann et al. Invest Ophthalmol Vis Sci. 2003 Aug.
Abstract
Purpose: Macrophage recruitment to the choroid has been proposed to contribute to the pathogenesis of choroidal neovascularization (CNV) in AMD. The study was conducted to determine whether treatment with clodronate liposomes (CL(2)MDP-lip), which cause depletion of blood monocytes and lymph node macrophages, diminishes the severity of neovascularization in a mouse model of laser-induced CNV.
Methods: Laser-induced CNV was performed in female 16-month-old C57BL/6 mice. Macrophages were depleted by use of CL(2)MDP-lip intraperitoneally and subcutaneously 72 and 24 hours before and every 2 to 3 days after laser injury. Control mice received injections of either PBS alone or PBS liposomes. Blood monocyte and choroidal macrophage depletion were documented by flow cytometry and choroidal flatmount preparation analysis, respectively. Two weeks after laser injury, mice were injected intravenously with fluoresceinated dextran. The right eyes were removed and prepared for flatmount analysis of CNV surface area (in relative disc areas or DA), vascularity (relative fluorescence), and cellularity (propidium iodide stain). The mice were then perfused with 10% formaldehyde, and the left eyes were removed for histopathology. The means of the various parameters for four CNV lesions per eye were calculated. Fluorescein angiography was also performed.
Results: Flow cytometry of circulating monocytes and immunohistochemical analysis of choroidal macrophage density confirmed the effective depletion of blood monocytes and choroidal macrophages respectively in CL(2)MDP-lip-treated mice. Compared with the control, flatmount analysis of macrophage depleted mice demonstrated a significant reduction in size of the CNV area (2.8 +/- 0.5 DA vs. 1.4 +/- 0.1 DA; P < 0.043). The treated group also revealed less vascularity (1.6 +/- 0.1 units vs. 1.1 +/- 0.0 units; P < 0.0092) and cellularity of CNV lesions (3.3 +/- 0.6 DA vs. 1.7 +/- 0.1 DA, P < 0.04). Histopathology revealed that, in the macrophage-depleted group, CNV was smaller in diameter (1270 +/- 73 pixels vs. 770 +/- 82 pixels, P < 0.0006) and thickness (120 +/- 7 pixels vs. 96 +/- 7 pixels, P < 0.019).
Conclusions: Macrophage depletion using CL(2)MDP-lip reduces size, cellularity, and vascularity of CNV. This observation supports the hypothesis that macrophages contribute to the severity of CNV lesions.
Similar articles
- Macrophage depletion inhibits experimental choroidal neovascularization.
Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Sakurai E, et al. Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3578-85. doi: 10.1167/iovs.03-0097. Invest Ophthalmol Vis Sci. 2003. PMID: 12882810 - Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells.
Shi YY, Wang YS, Zhang ZX, Cai Y, Zhou J, Hou HY, van Rooijen N. Shi YY, et al. Graefes Arch Clin Exp Ophthalmol. 2011 Nov;249(11):1667-79. doi: 10.1007/s00417-011-1699-4. Epub 2011 Jun 8. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21655971 - Age as an independent risk factor for severity of experimental choroidal neovascularization.
Espinosa-Heidmann DG, Suner I, Hernandez EP, Frazier WD, Csaky KG, Cousins SW. Espinosa-Heidmann DG, et al. Invest Ophthalmol Vis Sci. 2002 May;43(5):1567-73. Invest Ophthalmol Vis Sci. 2002. PMID: 11980875 - Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.
Tolentino MJ, Husain D, Theodosiadis P, Gragoudas ES, Connolly E, Kahn J, Cleland J, Adamis AP, Cuthbertson A, Miller JW. Tolentino MJ, et al. Arch Ophthalmol. 2000 Jan;118(1):78-84. doi: 10.1001/archopht.118.1.78. Arch Ophthalmol. 2000. PMID: 10636419 - [Effect of anti-TNF-alpha on laser-induced choroidal neovascularization].
Shi X, Semkova I, Kociok N, Gavranic C, Becker M, Joussen AM, Kirchhof B. Shi X, et al. Zhonghua Yan Ke Za Zhi. 2008 Mar;44(3):200-6. Zhonghua Yan Ke Za Zhi. 2008. PMID: 18785541 Chinese.
Cited by
- miRNAs as potential therapeutic targets for age-related macular degeneration.
Wang S, Koster KM, He Y, Zhou Q. Wang S, et al. Future Med Chem. 2012 Mar;4(3):277-87. doi: 10.4155/fmc.11.176. Future Med Chem. 2012. PMID: 22393936 Free PMC article. Review. - Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration.
Chen J, Connor KM, Smith LE. Chen J, et al. J Clin Invest. 2007 Oct;117(10):2758-62. doi: 10.1172/JCI33513. J Clin Invest. 2007. PMID: 17909623 Free PMC article. - Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina.
Ding XQ, Quiambao AB, Fitzgerald JB, Cooper MJ, Conley SM, Naash MI. Ding XQ, et al. PLoS One. 2009 Oct 12;4(10):e7410. doi: 10.1371/journal.pone.0007410. PLoS One. 2009. PMID: 19823583 Free PMC article. - Animal models of choroidal and retinal neovascularization.
Grossniklaus HE, Kang SJ, Berglin L. Grossniklaus HE, et al. Prog Retin Eye Res. 2010 Nov;29(6):500-19. doi: 10.1016/j.preteyeres.2010.05.003. Epub 2010 May 19. Prog Retin Eye Res. 2010. PMID: 20488255 Free PMC article. Review. - Therapeutic Benefit of Melatonin in Choroidal Neovascularization During Aging Through the Regulation of Senescent Macrophage/Microglia Polarization.
Cui K, Tang X, Hu A, Fan M, Wu P, Lu X, Lin J, Yang F, Zhao X, Huang J, Yu S, Xu Y, Liang X. Cui K, et al. Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):19. doi: 10.1167/iovs.64.11.19. Invest Ophthalmol Vis Sci. 2023. PMID: 37578424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources